 policy all mixed together and that was in the throes of the biotech revolution and the program I ran we approved like the first drug for cystic fibrosis we approved a drug for multiple sclerosis that was really became a standard of care for quite a long time although that was a fight to get it through that was about the first time I learned about some of the agencies